Flavan-3-ols consumption and cancer risk: A meta-analysis of epidemiologic studies

Oncotarget

Volumn 7, Issue 45, 2016, Pages 73573-73592

  Lei, Lei ^a,b   Yang, Ying ^a,b   He, Hongjuan ^a,b   Chen, Erfei ^a,b   Du, Le ^a,b   Dong, Jing ^a,b   Yang, Jin ^a,b  

^a NORTHWEST UNIVERSITY   (China)

^b Faculty of Preventive Medicine   (China)

Author keywords

Breast cancer; Cancer; Colorectal cancer; Flavan 3 ols; Meta analysis

Indexed keywords

CATECHIN; FLAVAN 3 OL; FLAVONOID; UNCLASSIFIED DRUG; FLAVAN-3-OL;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; FOOD INTAKE; GENETIC HETEROGENEITY; HUMAN; IN VITRO STUDY; LARYNX CANCER; META ANALYSIS; OROPHARYNX CANCER; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; RISK ASSESSMENT; STOMACH CANCER; SYSTEMATIC REVIEW; DIET; NEOPLASM; ODDS RATIO; RISK;

DIET; FLAVONOIDS; HUMANS; NEOPLASMS; ODDS RATIO; RISK;

EID: 84995785732     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12017     Document Type: Article

References (103)

1. Bhagwat S, Haytowitz DB, Holden JM. USDA database for the flavonoid content of selected foods, Release 3.1. Beltsville: US Department of Agriculture. 2011:03-01.
2. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of US adults. The Journal of nutrition. 2007; 137:1244-1252.
3. Aron PM, Kennedy JA. Flavan-3-ols: Nature, occurrence and biological activity. Molecular nutrition & food research. 2008; 52:79-104.
4. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a metaanalysis of randomized controlled trials. The American journal of clinical nutrition. 2008; 88:38-50.
5. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, Cassidy A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. The American journal of clinical nutrition. 2012; 95:740-751.
6. Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. The American journal of clinical nutrition. 2009; 89:1155-1163.
7. Yang W-S, Va P, Wong M-Y, Zhang H-L, Xiang Y-B. Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies. The American journal of clinical nutrition. 2011; 94:1575-1583.
8. Bors W, Michel C, Stettmaier K. Electron paramagnetic resonance studies of radical species of proanthocyanidins and gallate esters. Archives of Biochemistry and Biophysics. 2000; 374:347-355.
9. Cos P, Bruyne T, Hermans N, Apers S, Berghe DV, Vlietinck A. Proanthocyanidins in health care: current and new trends. Current medicinal chemistry. 2004; 11:1345-1359.
10. Galati G, O'Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radical Biology and Medicine. 2004; 37:287-303.
11. Chung L, Cheung T, Kong S, Fung K, Choy Y, Chan Z, Kwok T. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life sciences. 2001; 68:1207-1214.
12. Horie N, Hirabayashi N, Takahashi Y, Miyauchi Y, Taguchi H, Takeishi K. Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells. Biological and Pharmaceutical Bulletin. 2005; 28:574-579.
13. Tan X, Hu D, Li S, Han Y, Zhang Y, Zhou D. Differences of four catechins in cell cycle arrest and induction of apoptosis in LoVo cells. Cancer letters. 2000; 158:1-6.
14. Sharma SD, Katiyar SK. Dietary grape-seed proanthocyanidin inhibition of ultraviolet B-induced immune suppression is associated with induction of IL-12. Carcinogenesis. 2005; 27:95-102.
15. Haza AI, Morales P. Effects of (+) catechin and (-) epicatechin on heterocyclic amines-induced oxidative DNA damage. Journal of Applied Toxicology. 2011; 31:53-62.
16. Yance DR, Sagar SM. Targeting angiogenesis with integrative cancer therapies. Integrative cancer therapies. 2006; 5:9-29.
17. Guruvayoorappan C, Kuttan G. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-α in LPS-stimulated macrophages. Innate immunity. 2008; 14:160-174.
18. Ramiro E, Franch À, Castellote C, Pérez-Cano F, Permanyer J, Izquierdo-Pulido M, Castell M. Flavonoids from Theobroma cacao down-regulate inflammatory mediators. Journal of agricultural and food chemistry. 2005; 53:8506-8511.
19. Schroeder P, Klotz L-O, Buchczyk DP, Sadik CD, Schewe T, Sies H. Epicatechin selectively prevents nitration but not oxidation reactions of peroxynitrite. Biochemical and biophysical research communications. 2001; 285:782-787.
20. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M. Green tea (Camellia sinensis) for the prevention of cancer. The Cochrane Library. 2009.
21. Rossi M, Negri E, Parpinel M, Lagiou P, Bosetti C, Talamini R, Montella M, Giacosa A, Franceschi S, La Vecchia C. Proanthocyanidins and the risk of colorectal cancer in Italy. Cancer Causes & Control. 2010; 21:243-250.
22. Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, Ashby J, Slattery ML, Caan B, Paskett E, Iber F. Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiology Biomarkers & Prevention. 2008; 17:1344-1353.
23. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer research. 2006; 66:1234-1240.
24. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teitelbaum SL. Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiology Biomarkers & Prevention. 2007; 16:2285-2292.
25. Kyrø C, Zamora-Ros R, Scalbert A, Tjønneland A, Dossus L, Johansen C, Bidstrup PE, Weiderpass E, Christensen J, Ward H. Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Breast cancer research and treatment. 2015; 154:389-401.
26. Sun C-L, Yuan J-M, Lee M-J, Yang CS, Gao Y-T, Ross RK, Mimi CY. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis. 2002; 23:1497-1503.
27. Yuan JM, Gao YT, Yang CS, Yu MC. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. International journal of cancer. 2007; 120:1344-1350.
28. Luo J, Gao Y-T, Chow W-H, Shu X-O, Li H, Yang G, Cai Q, Rothman N, Cai H, Shrubsole MJ. Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study. Breast cancer research and treatment. 2010; 120:693-702.
29. Luo J, Gao YT, Chow WH, Shu Xo, Li H, Yang G, Cai Q, Li G, Rothman N, Cai H. Urinary polyphenols, glutathione S-transferases copy number variation, and breast cancer risk: Results from the Shanghai women's health study. Molecular carcinogenesis. 2012; 51:379-388.
30. Butler LM, Huang JY, Wang R, Lee M-J, Yang CS, Gao Y-T, Yuan J-M. Urinary Biomarkers of Catechins and Risk of Hepatocellular Carcinoma in the Shanghai Cohort Study. American journal of epidemiology. 2015; 181:397-405.
31. Iwasaki M, Inoue M, Sasazuki S, Miura T, Sawada N, Yamaji T, Shimazu T, Willett WC, Tsugane S. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. Breast cancer research and treatment. 2010; 124:827-834.
32. Sasazuki S, Inoue M, Miura T, Iwasaki M, Tsugane S. Plasma tea polyphenols and gastric cancer risk: a casecontrol study nested in a large population-based prospective study in Japan. Cancer Epidemiology Biomarkers & Prevention. 2008; 17:343-351.
33. Arts IC, Jacobs Jr DR, Gross M, Harnack LJ, Folsom AR. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes & Control. 2002; 13:373-382.
34. Touvier M, Druesne-Pecollo N, Kesse-Guyot E, Andreeva VA, Fezeu L, Galan P, Hercberg S, Latino-Martel P. Dual association between polyphenol intake and breast cancer risk according to alcohol consumption level: a prospective cohort study. Breast cancer research and treatment. 2013; 137:225-236.
35. Simons CC, Hughes LA, Arts IC, Goldbohm RA, van den Brandt PA, Weijenberg MP. Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study. International journal of cancer. 2009; 125:2945-2952.
36. Arts IC, Hollman PC, Bueno de Mesquita HB, Feskens EJ, Kromhout D. Dietary catechins and epithelial cancer incidence: the Zutphen elderly study. International journal of cancer. 2001; 92:298-302.
37. Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT, Cai L, Cozen W, Mack TM, Lu QY, Zhang ZF. Dietary flavonoid intake and lung cancer-A population-based casecontrol study. Cancer. 2008; 112:2241-2248.
38. Geybels MS, Verhage BA, Arts IC, Van Schooten FJ, Goldbohm RA, Van Den Brandt PA. Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer. American journal of epidemiology. 2013; 177:1388-1398.
39. Bobe G, Weinstein SJ, Albanes D, Hirvonen T, Ashby J, Taylor PR, Virtamo J, Stolzenberg-Solomon RZ. Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiology Biomarkers & Prevention. 2008; 17:553-562.
40. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clinical Cancer Research. 2005; 11:2735-2746.
41. Yang G-Y, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 1998; 19:611-616.
42. Agullo G, Gamet-Payrastre L, Fernandez Y, Anciaux N, Demigné C, Rémésy C. Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells). Cancer letters. 1996; 105:61-70.
43. Woo HD, Kim J. Dietary flavonoid intake and risk of stomach and colorectal cancer. World journal of gastroenterology. 2013; 19:1011.
44. Nimptsch K, Zhang X, Cassidy A, Song M, O'Reilly ÉJ, Lin JH, Pischon T, Rimm EB, Willett WC, Fuchs CS. Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts. The American journal of clinical nutrition. 2016; 103:184-191.
45. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000; 50:7-33.
46. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58:71-96.
47. Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P, Costa A, Daidone MG, Leo E, Pilotti S. Different genetic features associated with colon and rectal carcinogenesis. Clinical Cancer Research. 2004; 10:4015-4021.
48. Kapiteijn E, Liefers G, Los L, Klein Kranenbarg E, Hermans J, Tollenaar R, Moriya Y, van de Velde C, van Krieken J. Mechanisms of oncogenesis in colon versus rectal cancer. The Journal of pathology. 2001; 195:171-178.
49. Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett WC, Colditz GA. Comparison of risk factors for colon and rectal cancer. International journal of cancer. 2004; 108:433-442.
50. Hui C, Qi X, Qianyong Z, Xiaoli P, Jundong Z, Mantian M. Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One. 2013; 8:e54318.
51. Pérez-Jiménez J, Hubert J, Hooper L, Cassidy A, Manach C, Williamson G, Scalbert A. Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review. The American journal of clinical nutrition. 2010:ajcn. 29924.
52. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American journal of clinical nutrition. 2005; 81:230S-242S.
53. Inoue M, Sasazuki S, Wakai K, Suzuki T, Matsuo K, Shimazu T, Tsuji I, Tanaka K, Mizoue T, Nagata C. Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies. Gut. 2009.
54. Freedman ND, Chow W-H, Gao Y-T, Shu X-O, Ji B-T, Yang G, Lubin JH, Li H-L, Rothman N, Zheng W. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut. 2007; 56:1671-1677.
55. Lindblad M, Rodriguez LG, Chandanos E, Lagergren J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. British journal of cancer. 2006; 94:136-141.
56. Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 2011.
57. Goodin M, Fertuck K, Zacharewski T, Rosengren R. Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro. Toxicological Sciences. 2002; 69:354-361.
58. Romagnolo DF, Selmin OI. Flavonoids and cancer prevention: a review of the evidence. Journal of nutrition in gerontology and geriatrics. 2012; 31:206-238.
59. Tang N-P, Zhou B, Wang B, Yu R-B, Ma J. Flavonoids intake and risk of lung cancer: a meta-analysis. Japanese journal of clinical oncology. 2009; 39:352-359.
60. Woo HD, Kim J. Dietary flavonoid intake and smokingrelated cancer risk: a meta-analysis. PLoS One. 2013; 8:e75604.
61. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. Journal of the National Cancer Institute. 2006; 98:459-471.
62. Wells G, Shea B, O'connell D, Peterson J, Welch V, Losos M, Tugwell P. (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
63. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. The American journal of clinical nutrition. 1997; 65:1220S-1228S.
64. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986; 7:177-188.
65. Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002; 21:1539-1558.
66. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994:1088-1101.
67. Egger M, Smith GD, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. Bmj. 1997; 315:629-634.
68. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56:455-463.
69. Zamora-Ros R, Sacerdote C, Ricceri F, Weiderpass E, Roswall N, Buckland G, St-Jules D, Overvad K, Kyrø C, Fagherazzi G. Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. British journal of cancer. 2014.
70. Bosetti C, Spertini L, Parpinel M, Gnagnarella P, Lagiou P, Negri E, Franceschi S, Montella M, Peterson J, Dwyer J. Flavonoids and breast cancer risk in Italy. Cancer Epidemiology Biomarkers & Prevention. 2005; 14:805-808.
71. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer risk among women on Long Island. American journal of epidemiology. 2007; 165:514-523.
72. Peterson J, Lagiou P, Samoli E, Lagiou A, Katsouyanni K, La Vecchia C, Dwyer J, Trichopoulos D. Flavonoid intake and breast cancer risk: a case-control study in Greece. British journal of cancer. 2003; 89:1255-1259.
73. Torres-Sanchez L, Galvan-Portillo M, Wolff MS, Lopez-Carrillo L. Dietary consumption of phytochemicals and breast cancer risk in Mexican women. Public health nutrition. 2009; 12:825-831.
74. Wang Y, Gapstur SM, Gaudet MM, Peterson JJ, Dwyer JT, McCullough ML. Evidence for an Association of Dietary Flavonoid Intake with Breast Cancer Risk by Estrogen Receptor Status Is Limited. The Journal of nutrition. 2014; 144:1603-1611.
75. Zamora-Ros R, Ferrari P, González CA, Tjønneland A, Olsen A, Bredsdorff L, Overvad K, Touillaud M, Perquier F, Fagherazzi G. Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Breast cancer research and treatment. 2013; 139:163-176.
76. Kyle JA, Sharp L, Little J, Duthie GG, McNeill G. Dietary flavonoid intake and colorectal cancer: a case-control study. British journal of nutrition. 2010; 103:429-436.
77. Mursu J, Nurmi T, Tuomainen TP, Salonen JT, Pukkala E, Voutilainen S. Intake of flavonoids and risk of cancer in Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. International journal of cancer. 2008; 123:660-663.
78. Rossi M, Negri E, Talamini R, Bosetti C, Parpinel M, Gnagnarella P, Franceschi S, Dal Maso L, Montella M, Giacosa A. Flavonoids and colorectal cancer in Italy. Cancer Epidemiology Biomarkers & Prevention. 2006; 15:1555-1558.
79. Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, Barnetson R, Porteous M, Dunlop M, Campbell H. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiology Biomarkers & Prevention. 2007; 16:684-693.
80. Zamora-Ros R, Not C, Guinó E, Luján-Barroso L, García RM, Biondo S, Salazar R, Moreno V. Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study). Cancer Causes & Control. 2013; 24:549-557.
81. Bobe G, Peterson JJ, Gridley G, Hyer M, Dwyer JT, Brown LM. Flavonoid consumption and esophageal cancer among black and white men in the United States. International journal of cancer. 2009; 125:1147-1154.
82. Petrick J, Steck S, Bradshaw P, Trivers K, Abrahamson P, Engel L, He K, Chow W, Mayne S, Risch H. Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA). British journal of cancer. 2015.
83. Rossi M, Garavello W, Talamini R, La Vecchia C, Franceschi S, Lagiou P, Zambon P, Maso LD, Bosetti C, Negri E. Flavonoids and risk of squamous cell esophageal cancer. International journal of cancer. 2007; 120:1560-1564.
84. Vermeulen E, Zamora-Ros R, Duell EJ, Luján-Barroso L, Boeing H, Aleksandrova K, Bueno-de-Mesquita HB, Scalbert A, Romieu I, Fedirko V. Dietary flavonoid intake and esophageal cancer risk in the European prospective investigation into cancer and nutrition cohort. American journal of epidemiology. 2013; 178:570-581.
85. Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, Dwyer J, Trichopoulos D. Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes & Control. 2004; 15:67-72.
86. Rossi M, Rosato V, Bosetti C, Lagiou P, Parpinel M, Bertuccio P, Negri E, La Vecchia C. Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes & Control. 2010; 21:1597-1604.
87. Woo HD, Lee J, Choi IJ, Kim CG, Lee JY, Kwon O, Kim J. Dietary Flavonoids and Gastric Cancer Risk in a Korean Population. Nutrients. 2014; 6:4961-4973.
88. Zamora-Ros R, Agudo A, Luján-Barroso L, Romieu I, Ferrari P, Knaze V, Bueno-de-Mesquita HB, Leenders M, Travis RC, Navarro C. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. The American journal of clinical nutrition. 2012; 96:1398-1408.
89. Rossi M, Garavello W, Talamini R, Negri E, Bosetti C, Dal Maso L, Lagiou P, Tavani A, Polesel J, Barzan L. Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiology Biomarkers & Prevention. 2007; 16:1621-1625.
90. Garavello W, Rossi M, McLaughlin J, Bosetti C, Negri E, Lagiou P, Talamini R, Franceschi S, Parpinel M, Dal Maso L. Flavonoids and laryngeal cancer risk in Italy. Annals of oncology. 2007.
91. Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C, Trichopoulos D. Flavonoid intake and liver cancer: a case-control study in Greece. Cancer Causes & Control. 2008; 19:813-818.
92. Zamora-Ros R, Fedirko V, Trichopoulou A, González CA, Bamia C, Trepo E, Nöthlings U, Duarte-Salles T, Serafini M, Bredsdorff L. Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study. International journal of cancer. 2013; 133:2429-2443.
93. Christensen KY, Naidu A, Parent M-é, Pintos J, Abrahamowicz M, Siemiatycki J, Koushik A. The risk of lung cancer related to dietary intake of flavonoids. Nutrition and cancer. 2012; 64:964-974.
94. Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR, Scrafford CG, Barraj LM, Mink PJ, Robien K. Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. International journal of cancer. 2008; 123:664-671.
95. Lagiou P, Samoli E, Lagiou A, Katsouyanni K, Peterson J, Dwyer J, Trichopoulos D. Flavonoid intake in relation to lung cancer risk: case-control study among women in Greece. Nutrition and cancer. 2004; 49:139-143.
96. Rossi M, Negri E, Lagiou P, Talamini R, Dal Maso L, Montella M, Franceschi S, La Vecchia C. Flavonoids and ovarian cancer risk: a case-control study in Italy. International journal of cancer. 2008; 123:895-898.
97. Arem H, Bobe G, Sampson J, Subar A, Park Y, Risch H, Hollenbeck A, Mayne S, Stolzenberg-Solomon R. Flavonoid intake and risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study Cohort. British journal of cancer. 2013; 108:1168-1172.
98. Rossi M, Lugo A, Lagiou P, Zucchetto A, Polesel J, Serraino D, Negri E, Trichopoulos D, La Vecchia C. Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in Italy. Annals of oncology. 2012; 23:1488-1493.
99. Bosetti C, Bravi F, Talamini R, Parpinel M, Gnagnarella P, Negri E, Montella M, Lagiou P, Franceschi S, La Vecchia C. Flavonoids and prostate cancer risk: a study in Italy. Nutrition and cancer. 2006; 56:123-127.
100. Wang Y, Stevens VL, Shah R, Peterson JJ, Dwyer JT, Gapstur SM, McCullough ML. Dietary flavonoid and proanthocyanidin intakes and prostate cancer risk in a prospective cohort of US men. American journal of epidemiology. 2014; 179:974-986.
101. Bosetti C, Rossi M, McLaughlin JK, Negri E, Talamini R, Lagiou P, Montella M, Ramazzotti V, Franceschi S, LaVecchia C. Flavonoids and the risk of renal cell carcinoma. Cancer Epidemiology Biomarkers & Prevention. 2007; 16:98-101.
102. Xiao Q, Park Y, Hollenbeck AR, Kitahara CM. Dietary flavonoid intake and thyroid cancer risk in the NIH-AARP diet and health study. Cancer Epidemiology Biomarkers & Prevention. 2014; 23:1102-1108.
103. Rossi M, Edefonti V, Parpinel M, Lagiou P, Franchi M, Ferraroni M, Decarli A, Zucchetto A, Serraino D, Dal Maso L. Proanthocyanidins and other flavonoids in relation to endometrial cancer risk: a case-control study in Italy. British journal of cancer. 2013; 109:1914-1920.